Tamoxifen Alternatives Compared
Tamoxifen | Verzenio (abemaciclib) | Kisqali (ribociclib) |
|
---|
Tamoxifen | Verzenio (abemaciclib) | Kisqali (ribociclib) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Male, Breast Cancer, Breast Cancer - Palliative, Breast Cancer - Prevention, McCune-Albright Syndrome, Precocious... View more |
Prescription only
Verzenio (abemaciclib) is a targeted treatment that helps to reduce the growth and spread of cancer cells in the body. It may be used to treat HR+ HER2-, node-positive, early breast cancer at high... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. Kisqali may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||||||||||
More about Tamoxifen | More about Verzenio (abemaciclib) | More about Kisqali (ribociclib) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Tamoxifen has an average rating of 5.6 out of 10 from a total of 98 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 29% reported a negative effect. |
Verzenio has an average rating of 7.7 out of 10 from a total of 37 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 8% reported a negative effect. |
Kisqali has an average rating of 8.6 out of 10 from a total of 34 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 3% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Tamoxifen side effects |
View all Verzenio side effects |
View all Kisqali side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Tamoxifen prices |
View all Verzenio prices |
View all Kisqali prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Soltamox |
N/A |
N/A |
||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
231 hours |
24.8 hours |
54.7 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 463 drugs are known to interact with Tamoxifen:
|
A total of 357 drugs are known to interact with Verzenio:
|
A total of 748 drugs are known to interact with Kisqali:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
December 30, 1977 |
September 28, 2017 |
March 13, 2017 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.